Alpha Centric Advisors LLC Fusion Pharmaceuticals Inc. Transaction History

Alpha Centric Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	SELL	$2.0 - $3.56 $200,000 - $356,000	-100,000 Closed	0 $0
Q4 2021 Feb 25, 2022	BUY	$4.17 - $7.78 $118,845 - $221,730	28,500 Added 39.86%	100,000 $417,000
Q2 2021 Mar 09, 2022	BUY	$7.97 - $10.66 $274,965 - $367,770	34,500 Added 93.24%	71,500 $578,000
Q1 2021 Mar 09, 2022	BUY	$9.75 - $13.09 $199,875 - $268,345	20,500 Added 124.24%	37,000 $397,000
Q4 2020 Mar 11, 2022	BUY	$11.5 - $13.73 $146,050 - $174,371	12,700 Added 334.21%	16,500 $194,000
Q3 2020 Mar 11, 2022	BUY	$11.8 - $17.1 $23,600 - $34,200	2,000 Added 111.11%	3,800 $46,000
Q2 2020 Mar 11, 2022	BUY	$17.0 - $17.78 $30,600 - $32,004	1,800 New	1,800 $31,000

93K

1.4K

Ticker FUSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,390,500
Description
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Centric Advisors LLC with notifications on news.